SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-23-000026
Filing Date
2023-08-03
Accepted
2023-08-03 16:14:59
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prta-20230630.htm   iXBRL 10-Q 1308645
2 EX-31.1 prta2023q210-qxex311.htm EX-31.1 11075
3 EX-31.2 prta2023q210-qxex312.htm EX-31.2 11188
4 EX-32.1 prta2023q210-qxex321.htm EX-32.1 8823
  Complete submission text file 0001559053-23-000026.txt   6524331

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20230630.xsd EX-101.SCH 58660
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20230630_cal.xml EX-101.CAL 78702
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20230630_def.xml EX-101.DEF 262223
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20230630_lab.xml EX-101.LAB 730946
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20230630_pre.xml EX-101.PRE 453721
61 EXTRACTED XBRL INSTANCE DOCUMENT prta-20230630_htm.xml XML 635742
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 231140195
SIC: 2834 Pharmaceutical Preparations